Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Definium Therapeutics, Inc.

NASDAQ: DFTX · Life Sciences · 9 alerts · CIK 1813814

Share price
$30.16Close, Nov 16
Market cap
$4.13B
Shares outstanding
136.9MLatest SEC cover page
Sector
Life Sciences
Industry
Medicinal Chemicals & Botanical ProductsSIC 2833

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Definium Therapeutics, Inc. filings on SEC EDGAR ↗

2:20 AM ET Form 4
Insider Selling

Definium Therapeutics CFO Brandi Roberts Sells $123K of Stock

Brandi Roberts, CFO, sold 3,377 shares of Definium Therapeutics, Inc. at $36.57 a share, worth $123K in total on Sep 25, 2026. Shares held after the trade: 394,528 (-0.8%).

Value
$123K
Shares
3,377
Price
$36.57
Role
CFO
Holding change
-0.8%
Trade date
Sep 25, 2026
2:20 AM ET Form 4
Insider Selling

Definium Therapeutics CLO Mark Sullivan Sells $514K of Stock

Mark Sullivan, CLO, sold 14,051 shares of Definium Therapeutics, Inc. at $36.57 a share, worth $514K in total on Sep 25, 2026. Shares held after the trade: 494,228 (-2.8%).

Value
$514K
Shares
14,051
Price
$36.57
Role
CLO
Holding change
-2.8%
Trade date
Sep 25, 2026
2:20 AM ET Form 4
Insider Selling

Definium Therapeutics Chief Commercial Officer Matthew T. Wiley Sells $113K of Stock

Matthew T. Wiley, Chief Commercial Officer, sold 3,097 shares of Definium Therapeutics, Inc. at $36.57 a share, worth $113K in total on Sep 25, 2026. Shares held after the trade: 359,036 (-0.9%).

Value
$113K
Shares
3,097
Price
$36.57
Role
Chief Commercial Officer
Holding change
-0.9%
Trade date
Sep 25, 2026
2:20 AM ET Form 4
Insider Selling

Definium Therapeutics CEO Robert Barrow Sells $1.15M of Stock

Robert Barrow, CEO, sold 31,550 shares of Definium Therapeutics, Inc. at $36.57 a share, worth $1.15M in total on Sep 25, 2026. Shares held after the trade: 2,213,090 (-1.4%).

Value
$1.15M
Shares
31,550
Price
$36.57
Role
CEO
Holding change
-1.4%
Trade date
Sep 25, 2026
2:20 AM ET Form 4
Insider Selling

Definium Therapeutics CMO Daniel Karlin Sells $397K of Stock

Daniel Karlin, CMO, sold 10,853 shares of Definium Therapeutics, Inc. at $36.57 a share, worth $397K in total on Sep 25, 2026. Shares held after the trade: 792,846 (-1.4%).

Value
$397K
Shares
10,853
Price
$36.57
Role
CMO
Holding change
-1.4%
Trade date
Sep 25, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.